IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v6y2015i1d10.1038_ncomms7537.html
   My bibliography  Save this article

The interferon-related developmental regulator 1 is used by human papillomavirus to suppress NFκB activation

Author

Listed:
  • Bart Tummers

    (Leiden University Medical Center)

  • Renske Goedemans

    (Leiden University Medical Center)

  • Laetitia P. L. Pelascini

    (Leiden University Medical Center)

  • Ekaterina S. Jordanova

    (Center for Gynaecological Oncology)

  • Edith M. G. van Esch

    (Leiden University Medical Center)

  • Craig Meyers

    (The Pennsylvania State University College of Medicine)

  • Cornelis J. M. Melief

    (Leiden University Medical Center)

  • Judith M. Boer

    (Leiden University Medical Center
    Present addresses: Department of Pediatric Oncology, Erasmus MC—Sophia Children’s Hospital, Wytemaweg 80, 3015CN Rotterdam, The Netherlands; Netherlands Bioinformatics Center, Geert Grooteplein-Zuid 28, 6525GA Nijmegen, The Netherlands.)

  • Sjoerd H. van der Burg

    (Leiden University Medical Center)

Abstract

High-risk human papillomaviruses (hrHPVs) infect keratinocytes and successfully evade host immunity despite the fact that keratinocytes are well equipped to respond to innate and adaptive immune signals. Using non-infected and freshly established or persistent hrHPV-infected keratinocytes we show that hrHPV impairs the acetylation of NFκB/RelA K310 in keratinocytes. As a consequence, keratinocytes display a decreased pro-inflammatory cytokine production and immune cell attraction in response to stimuli of the innate or adaptive immune pathways. HPV accomplishes this by augmenting the expression of interferon-related developmental regulator 1 (IFRD1) in an EGFR-dependent manner. Restoration of NFκB/RelA acetylation by IFRD1 shRNA, cetuximab treatment or the HDAC1/3 inhibitor entinostat increases basal and induced cytokine expression. Similar observations are made in IFRD1-overexpressing HPV-induced cancer cells. Thus, our study reveals an EGFR–IFRD1-mediated viral immune evasion mechanism, which can also be exploited by cancer cells.

Suggested Citation

  • Bart Tummers & Renske Goedemans & Laetitia P. L. Pelascini & Ekaterina S. Jordanova & Edith M. G. van Esch & Craig Meyers & Cornelis J. M. Melief & Judith M. Boer & Sjoerd H. van der Burg, 2015. "The interferon-related developmental regulator 1 is used by human papillomavirus to suppress NFκB activation," Nature Communications, Nature, vol. 6(1), pages 1-12, May.
    • Handle: RePEc:nat:natcom:v:6:y:2015:i:1:d:10.1038_ncomms7537
    DOI: 10.1038/ncomms7537
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/ncomms7537
    File Function: Abstract
    Download Restriction: no
    File URL: https://libkey.io/10.1038/ncomms7537?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Alizee Lebeau & Diane Bruyere & Patrick Roncarati & Paul Peixoto & Eric Hervouet & Gael Cobraiville & Bernard Taminiau & Murielle Masson & Carmen Gallego & Gabriel Mazzucchelli & Nicolas Smargiasso & , 2022. "HPV infection alters vaginal microbiome through down-regulating host mucosal innate peptides used by Lactobacilli as amino acid sources," Nature Communications, Nature, vol. 13(1), pages 1-20, December.
    2. Julia Joung & Paul C. Kirchgatterer & Ankita Singh & Jang H. Cho & Suchita P. Nety & Rebecca C. Larson & Rhiannon K. Macrae & Rebecca Deasy & Yuen-Yi Tseng & Marcela V. Maus & Feng Zhang, 2022. "CRISPR activation screen identifies BCL-2 proteins and B3GNT2 as drivers of cancer resistance to T cell-mediated cytotoxicity," Nature Communications, Nature, vol. 13(1), pages 1-14, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:6:y:2015:i:1:d:10.1038_ncomms7537. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.